Rifaximin Improves Clostridium difficile Toxin A-Induced Toxicity in Caco-2 Cells by the PXR-Dependent TLR4/MyD88/NF-κB Pathway

Background: Clostridium difficile infections (CDIs) caused by Clostridium difficile toxin A (TcdA) lead to severe ulceration, inflammation and bleeding of the colon, and are difficult to treat. Aim: The study aimed to evaluate the effect of rifaximin on TcdA-induced apoptosis in intestinal epithelia...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Giuseppe, Nobile, Nicola, Gigli, Stefano, Seguella, Luisa, Pesce, Marcella, d’Alessandro, Alessandra, Bruzzese, Eugenia, Capoccia, Elena, Steardo, Luca, Cuomo, Rosario, Sarnelli, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860461/
https://www.ncbi.nlm.nih.gov/pubmed/27242527
http://dx.doi.org/10.3389/fphar.2016.00120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860461/
https://www.ncbi.nlm.nih.gov/pubmed/27242527
http://dx.doi.org/10.3389/fphar.2016.00120

Ejemplares similares